{"DataElement":{"publicId":"3133781","version":"1","preferredName":"Derived Common Terminology Criteria for Adverse Events Version 4.0 Mapped Low Level Term or MedDRA Code and Other Specify Text","preferredDefinition":"A derived data element describing a rule for selection of a CTCAEv4.0 low level term system organ class - Other, Specify term, selecting a related a MedDRA code, and entering text to describe an adverse event that is not stated explicitly in the CTCAE v4.0 adverse event vocabulary.","longName":"DCTCAE4_M_LLTMCOS_TX","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2943909","version":"2","preferredName":"Adverse Event Common Terminology Criteria for Adverse Events Term","preferredDefinition":"Text term to represent the Common Terminology Criteria for Adverse Events preferred name for an adverse event.","longName":"AE_CTCAE_TRM","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2235992","version":"1","preferredName":"Adverse Event","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-74E9-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-15","modifiedBy":"ONEDATA","dateModified":"2005-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2747485","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Term","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.:A word or expression used for some particular thing.","longName":"C49704:C45559","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Term","conceptCode":"C45559","definition":"A word or expression used for some particular thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C96B352-8AFA-6D3A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"UMLLOADER_CAAERS","dateCreated":"2008-05-06","modifiedBy":"ONEDATA","dateModified":"2008-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTCAE:Common TerminologyCriteria for Adverse Events","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D680A5C-2528-3141-E040-BB89AD43657E","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-08-09","modifiedBy":"BMAESKE","dateModified":"2023-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3133780","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Version Integer::4.0 Mapped Low Level Term MedDRA Code System Organ Class Other Specify Text","preferredDefinition":"Text that describes an adverse event that is identified by  a CTCAE v4.0 system organ class (SOC) - Other, Specify term or a MedDRA code mapped to a system organ class - Other, Specify term.","longName":"DCTCAE4_M_LLTMCOS_TX","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"Derived","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3133779","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Version Integer::4.0 Mapping Table Term MedDRA Code Adverse Event by System Organ Class Other Specify Text","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.:Version; something a little different from others of the same type; one of a sequence of copies of a program, each incorporating new modifications.:A number with no fractional part.::4.0:A function, represented as a table, such that for every element of one set there is a unique element of another set.:A word or expression used for some particular thing.:An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle.  MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology.:A system of numbered categories for representation of data.:No Value Exists:Different than the one(s) previously specified or mentioned.:Be specific about something; define clearly.:Text; the words of something written.","longName":"3133779v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"10"},{"longName":"Version","conceptCode":"C25714","definition":"A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"9"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"8"},{"longName":"Mapping Table","conceptCode":"C45794","definition":"A function, represented as a table, such that for every element of one set there is a unique element of another set.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"Term","conceptCode":"C45559","definition":"A word or expression used for some particular thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"MedDRA","conceptCode":"C43820","definition":"An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Adverse Event by System Organ Class","conceptCode":"E10002","definition":"No Value Exists","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EC079DB-DF83-1143-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2010-08-26","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-08-26","modifiedBy":"ONEDATA","dateModified":"2010-08-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTCAEv4.0:Common Terminology Criteria for Adverse Events v4.0","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EC079DB-DF94-1143-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2010-08-26","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-08-26","modifiedBy":"CURTIST","dateModified":"2010-10-26","changeDescription":"NOTE:  In the permissible value list for this Value Domain the MedDRA codes that represent system organ categories have been mapped to the terms system organ class - Other, Specify not to the simple system organ category terms.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3121334","version":"1","longName":"CTCAE v4.0 CDEs","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3121335","version":"1","longName":"CTCAEv4.0","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Other, Specify Text:","type":"Preferred Question Text","description":"Other, Specify Text:","url":null,"context":"NCIP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Other CTC Adverse Event Term Not Listed (CTCAE v.4.0)","url":null,"context":"CTEP"}],"origin":"CTCAEv4.0:Common Terminology Criteria for Adverse Events v4.0","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EC079DC-23A7-1143-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2010-08-26","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-08-26","modifiedBy":"REEVESD","dateModified":"2011-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}